Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115479512 | 11547951 | 2 | F | 20160113 | 20150924 | 20160906 | PER | US-AMNEAL PHARMACEUTICALS-2015AMN00043 | AMNEAL | 0.00 | F | Y | 82.54000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115479512 | 11547951 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 1 CAPSULES, 3X/DAY | U | 78428 | 1 | DF | CAPSULE | TID | |||||
| 115479512 | 11547951 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | U | 78428 | CAPSULE | ||||||||||
| 115479512 | 11547951 | 3 | SS | LYRICA | PREGABALIN | 1 | 300 MG, 3X/DAY | 0 | 300 | MG | TABLET | TID | |||||||
| 115479512 | 11547951 | 4 | SS | LYRICA | PREGABALIN | 1 | 0 | TABLET | |||||||||||
| 115479512 | 11547951 | 5 | SS | ENBREL | ETANERCEPT | 1 | 50 MG/ML, 1X/MONTH | 0 | /month | ||||||||||
| 115479512 | 11547951 | 6 | C | LOVASTATIN. | LOVASTATIN | 1 | 1 TABLETS, 1X/DAY | 0 | 1 | DF | TABLET | QD | |||||||
| 115479512 | 11547951 | 7 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 2 MG, 1X/DAY | 0 | 2 | MG | TABLET | QD | |||||||
| 115479512 | 11547951 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD | |||||||
| 115479512 | 11547951 | 9 | C | Vitamin B12 Injection | 2 | 1000 MCG, 1X/MONTH | 0 | INJECTION | /month | ||||||||||
| 115479512 | 11547951 | 10 | C | Magoxide | 2 | 400 MG, 2X/DAY | 0 | 400 | MG | BID | |||||||||
| 115479512 | 11547951 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | 2.5 MG, 1X/WEEK | 0 | 2.5 | MG | /wk | ||||||||
| 115479512 | 11547951 | 12 | C | Oxycodone | OXYCODONE | 1 | 15 MG, 1X/DAY | 0 | 15 | MG | QD | ||||||||
| 115479512 | 11547951 | 13 | C | Morphine | MORPHINE | 1 | 60 MG, 2X/DAY | 0 | 60 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115479512 | 11547951 | 1 | Neuropathy peripheral |
| 115479512 | 11547951 | 2 | Arthritis |
| 115479512 | 11547951 | 3 | Neuropathy peripheral |
| 115479512 | 11547951 | 4 | Formication |
| 115479512 | 11547951 | 7 | Arthritis |
| 115479512 | 11547951 | 8 | Gastrooesophageal reflux disease |
| 115479512 | 11547951 | 9 | Vitamin B12 deficiency |
| 115479512 | 11547951 | 10 | Magnesium deficiency |
| 115479512 | 11547951 | 11 | Arthritis |
| 115479512 | 11547951 | 12 | Pain |
| 115479512 | 11547951 | 13 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115479512 | 11547951 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115479512 | 11547951 | 1 | 2013 | 0 | ||
| 115479512 | 11547951 | 3 | 201501 | 0 | ||
| 115479512 | 11547951 | 5 | 2015 | 0 | ||
| 115479512 | 11547951 | 8 | 2006 | 0 | ||
| 115479512 | 11547951 | 10 | 201501 | 0 | ||
| 115479512 | 11547951 | 11 | 201505 | 0 | ||
| 115479512 | 11547951 | 12 | 2006 | 0 | ||
| 115479512 | 11547951 | 13 | 2006 | 0 |